Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on April 15, 2025

KRONOS WORLDWIDE, INC. ANNOUNCES  EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE

KRONOS WORLDWIDE, INC. ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE

Dallas, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE: KRO) announced today that, subject to the completion of quarter-end closing procedures, it expects to report first quarter 2025 earnings in a press release after market close …

TEN Ltd. Announces the Filing of Form 20-F With the SEC

TEN Ltd. Announces the Filing of Form 20-F With the SEC

ATHENS, Greece, April 15, 2025 (GLOBE NEWSWIRE) -- TEN, Ltd. (TEN) (NYSE: TEN) (the “Company”) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, has been filed with the U.S. Securities and Exchange Commission …

Navitas Announces Automotive Qualification of High-Power GaNSafe™ ICs

Navitas Announces Automotive Qualification of High-Power GaNSafe™ ICs

TORRANCE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry leader in gallium nitride (GaN) power ICs and silicon carbide (SiC) technology, has …

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …

Diginex Limited and AIKYA Announce Strategic Alliance to Launch diginexESG in Malaysia, Advancing ESG Reporting and Sustainable Finance

Diginex Limited and AIKYA Announce Strategic Alliance to Launch diginexESG in Malaysia, Advancing ESG Reporting and Sustainable Finance

LONDON, April 15, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company specializing in environmental, social, and governance (“ESG”) solutions, today announced a strategic alliance with AIKYA, a leading …

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …

ARRAY Technologies, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

ARRAY Technologies, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

ALBUQUERQUE, N.M., April 15, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (Nasdaq: ARRY), a global leader in utility-scale solar tracking, today announced that the Company will release its first quarter 2025 results before …

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics

Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …

Ingredion to Release 2025 First Quarter Financial Results On May 6, 2025

Ingredion to Release 2025 First Quarter Financial Results On May 6, 2025

WESTCHESTER, Ill., April 15, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its first quarter 2025 financial results for the period ended …

Rapid7 to Report First Quarter 2025 Financial Results on May 12

Rapid7 to Report First Quarter 2025 Financial Results on May 12

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will release its first quarter 2025 financial results on Monday, May 12, 2025, after the financial …

Mondelēz International Continues Progress Against  “Snacking Made Right” Priorities

Mondelēz International Continues Progress Against “Snacking Made Right” Priorities

Showcases continued leadership and meaningful progress towards a more sustainable snacking business. Highlights include continued advancement in more sustainable sourcing, carbon emission reductions, recyclable packaging, and mindful portions. Demonstrates …

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …

Wireless Industry Veteran Ryan Sullivan Joins Inseego as Senior Vice President of Carrier Product Management

Wireless Industry Veteran Ryan Sullivan Joins Inseego as Senior Vice President of Carrier Product Management

SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG), a global leader in wireless broadband, 5G mobile, and fixed wireless access (FWA) solutions, today announced the appointment of Ryan Sullivan as Senior Vice President of Carrier …

Brilliant Earth to Report First Quarter 2025 Financial Results on May 6th

Brilliant Earth to Report First Quarter 2025 Financial Results on May 6th

SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that it will report first quarter 2025 …

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

MYR Group Inc. to Participate in Oppenheimer Annual Industrial Growth Conference in May

MYR Group Inc. to Participate in Oppenheimer Annual Industrial Growth Conference in May

THORNTON, Colo., April 15, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United …

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service